Tag: AstraZeneca

Updated results from the positive PACIFIC Phase III trial showed AstraZeneca’s Imfinzi (durvalumab) demonstrated a sustained, clinically meaningful ...

AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients ...

AstraZeneca’s COVID-19 vaccine, Vaxzevria (ChAdOx1-S ), formerly AZD1222, has been granted a special approval for emergency use in Japan for ...

NAVIGATOR Data Published in New England Journal of Medicine, and Latest Data from Tezepelumab Clinical Program ...

U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney ...

Nirsevimab is being investigated as a first-in-class single dose immunization to provide protection for all infants entering their first RSV season. Nirsevimab met its Phase ...

The benefits of vaccination continue to outweigh any risks but the MHRA advises careful consideration be given to ...

AstraZeneca issued statement that "there are no exports currently planned other than to COVAX countries. There ...

76% vaccine efficacy against symptomatic COVID-19 100% efficacy against severe or critical disease and hospitalisation 85% ...

The AstraZeneca US Phase III trial of AZD1222 demonstrated statistically significant vaccine efficacy of 79% at ...